Market Access Courses
In May and June Asger Lindvig delivered modules for the two Atrium courses “Cross-functional Market Access” and “Market Access Management and Regulations”. In the module “Cross-functional Market Access” he covered…
New publication: The economic burden of poor glycemic control within diabetes treatment.
We are proud to have been co-authoring this new publication: “The economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in Denmark”. The…
Increased synergies for HTA submissions in the Nordics!
With the introduction of the new DMC methods guideline, the requirements for submissions to the DMC changed quite significantly. Previously, the health economic report and clinical application should be submitted…
Need support for the new Danish Health Technology Council applications?
The new Danish Health Technology Council (HTC) is a reality. The HTC is established by the Danish Regions but will be a political independent prioritisation Health Technology Assessment (HTA) organ.…
Are you ready for negotiations with Amgros under the new DMC framework?
Following the change in the Danish Medicines Council’s assessment process, from January 1st 2021 a new framework for the negotiations with Amgros is now a reality. The legal framework and…
